doxazosin has been researched along with fesoterodine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andersson, KE; Brodsky, M; Christ, GJ; Füllhase, C; Gratzke, C; Soler, R | 2 |
1 review(s) available for doxazosin and fesoterodine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for doxazosin and fesoterodine
| Article | Year |
|---|---|
Urodynamic evaluation of fesoterodine metabolite, doxazosin and their combination in a rat model of partial urethral obstruction.
Topics: Adrenergic alpha-Antagonists; Animals; Benzhydryl Compounds; Doxazosin; Drug Therapy, Combination; Male; Muscarinic Antagonists; Rats; Rats, Sprague-Dawley; Treatment Outcome; Urethral Obstruction; Urodynamics | 2010 |
Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction.
Topics: Adrenergic alpha-Antagonists; Animals; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Male; Rats; Rats, Sprague-Dawley; Spinal Cord; Urethral Obstruction | 2010 |